Armistice Capital »

Royal Gold shares owned by Armistice Capital

Quarter-by-quarter ownership of Royal Gold (RGLD) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Royal Gold

Tip: Access up to 7 years of quarterly data

All positions including Royal Gold held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Royal Gold by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $294k 1.5k 199.61

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Cytokinetics Com New (CYTK)
Agios Pharmaceuticals (AGIO)
Madrigal Pharmaceuticals (MDGL)
Ptc Therapeutics I (PTCT)
Supernus Pharmaceuticals (SUPN)
Travere Therapeutics (TVTX)
Immunovant (IMVT)
Incyte Corporation (INCY)
Neurocrine Biosciences (NBIX)
UnitedHealth (UNH)
Mineralys Therapeutics (MLYS)
Freshpet (FRPT)
Dyne Therapeutics (DYN)

View all positions for Armistice Capital

Top funds holding Royal Gold

BlackRock
Capital World Investors
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
Van Eck Associates Corp.
Invesco
Geode Capital Management
Capital Research Global Investors
Norges Bank Investment Management
UBS Group
AQR Capital Management
Morgan Stanley
Northern Trust
First Eagle Investment Management

View all funds holding Royal Gold